Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases

This innovative approach not only enhances local drug delivery but also minimizes systemic side effects, addressing a critical challenge in GBM treatment. These cases highlight the potential of this protocol as an adjunct to standard therapies, offering a promising option for managing inoperable or recurrent GBM.